Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.14 USD | -3.10% | -5.84% | +122.54% |
05-13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
05-08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+122.54% | 604M | |
+65.17% | 62.59B | |
-1.48% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.40% | 26.21B | |
-21.78% | 19.09B | |
+4.90% | 13.08B | |
+25.47% | 12.26B | |
+28.61% | 12.05B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Transcript : Mind Medicine Inc., Q2 2023 Earnings Call, Aug 03, 2023